Hey Super - I agree with Bishy and bonchien (good dog) but not ProMaster on this one - In Canada it will have a lot of merit that Health Canada has approved ActiPatch and ALLAY for OTC sales in that country - IMO FDA approval means little. The Canadian door is open, sell it there and now!
So, I continue to scream (in lower case) "make the deal BIEL". I would be astounded if the CEO of BIEL does not agree with me wholeheartedly. I will go so far as to say if he does not agree, he should be replaced yesterday. I would bventure to say that J&J or P&G would have it in Canadian retail pharmacies by now. They would throw the dough and the manpower behing the product line and make it happen because they are powerful machines. I am mindful of part of Mr. Whelan's radio interview when he said "we're not sharing". Only a fool doesn't change his mind and I would rather have a smaller piece of a bigger pie, thank you.
For BIEL to make a deal in Canada will continue to embarrass us in the US - meanwhile fight the good fight at FDA - they know by now that they made an error, if what the company is telling us the truth in the President's letter to shareholders. There are numerous astute posters here who support that the FDA made a colossal error in its assessment of the technical aspects of ALLAY - they may well be trying to figure out as to how to save face - an important part of the regulatory process.
Make a retail pharma deal BIEL - even if you have to put 100,000 units into Canadian pharmacies on consignment - do something!
